Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Annual Report on Global Diabetic Retinopathy Industry 2016

Monday, October 24, 2016 23:37
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to the report “Diabetic Retinopathy” Market by Type of Treatment, By Indication, By End Users and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021), published by Market Data Forecast, the global market is projected to reach USD 8.52 Billion by 2021, at a CAGR of 6.9% in the forecast period.

For full report refer to http://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/

Diabetic retinopathy is a complication of diabetes, caused by high blood sugar levels damaging the back of the eye (retina). It can cause blindness if left undiagnosed and untreated. These conditions can result in blurring of your vision, haemorrhage into your eye, or, if untreated, retinal detachment. Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in the United States.

Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/request-sample

Growth enhancing factors are government initiatives, abundant R&D activities, and skill set enhancement of healthcare providers. Increased health awareness and rising disposable income in developing countries has increased the advanced healthcare services, affordability; which interns driving the market of diabetic retinopathy. 

Request Customization at http://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/customize-report

By Type of Treatment:
•Anti-Vascular Endothelial Growth Factor (VEGF) drug
•Intraocular Steroid Injection
•Laser Surgery
•Vitrectomy

By Indication:
•Non-Proliferative Diabetic Retinopathy (NPDR)
a)Mild
b)Moderate
c)Severe
•Proliferative Diabetic Retinopathy (PDR)

By End Users:
•Hospitals
•Ophthalmic Clinics
•Ambulatory Surgical Centers

By Geography:
•North America
•Europe
•Asia-Pacific
•Latin America
•Middle-East and Africa

Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/inquire

The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.

Buy now https://www.marketdataforecast.com/cart/buy-now/global-diabetic-retinopathy-market-936

About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact:
Market Data Forecast, Inc.
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com
 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.